Bespoke Extracts, Inc.

BSPK

US08634Q2084

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 07:39:57 09/05/2024 pm IST			5-day change	1st Jan Change
0.15 ^USD	+87.50%		+36.36%	+322.54%

18/04	Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
16/02	Bespoke Extracts, Inc. announced that it has received $0.1 million in funding	CI

Bespoke Extracts, Inc. announced that it has received $0.0922 million in funding from Infinity Management LLC and other investors

June 30, 2022

On June 30, 2022, Bespoke Extracts, Inc. closed the transaction. The transaction included participation from Infinity Management, LLC for 8,000,000 common shares and warrants to purchase 2,000,000 shares of common stock, for an aggregate purchase price of $40,000.

Latest news about Bespoke Extracts, Inc.

Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18/04	CI
Bespoke Extracts, Inc. announced that it has received $0.1 million in funding	16/02	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	17/01	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/23/28	CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	14/23/14	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI
Bespoke Extracts, Inc. Auditor Raises 'Going Concern' Doubt	27/23/27	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22/22/22	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	20/22/20	CI
Bespoke Extracts, Inc. entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million.	12/22/12	CI
Bespoke Extracts, Inc. announced that it has received $0.0922 million in funding from Infinity Management LLC and other investors	30/22/30	CI
Bespoke Extracts, Inc. announced that it expects to receive $0.0922 million in funding from Infinity Management LLC and other investors	23/22/23	CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Four Months Ended December 31, 2021	25/22/25	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Four Months Ended December 31, 2021	25/22/25	CI
Bespoke Extracts, Inc. Changes Fiscal Year from August 31 to December 31	04/22/04	CI
Bespoke Extracts, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021	20/22/20	CI
Bespoke Extracts, Inc. announced that it has received $0.25 million in funding	31/21/31	CI
Bespoke Extracts, Inc. announced that it expects to receive $0.25 million in funding	27/21/27	CI
Bespoke Extracts, Inc. Announces Appointment of Hunter Garth as President	15/21/15	CI
Bespoke Extracts, Inc. Reports Earnings Results for the Full Year Ended August 31, 2021	14/21/14	CI
Bespoke Extracts, Inc. Auditor Raises 'Going Concern' Doubt	13/21/13	CI
Bespoke Extracts, Inc. agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million.	02/21/02	CI
Infinity Management LLC completed the acquisition of 20.1% stake in Bespoke Extracts, Inc. from Danil Pollack.	19/21/19	CI
Bespoke Extracts, Inc. Announces Management Changes	29/21/29	CI

Chart Bespoke Extracts, Inc.

Duration

Period

More charts

Company Profile

Bespoke Extracts, Inc. operates in the regulated cannabis markets in the United States. The Company owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including Fresh Joints, Box-O-Joints, and Wee Joints, to licensed marijuana dispensaries across Colorado. Through its wholly owned subsidiary, Bespoke Extracts Colorado, LLC, the Company operates Wonderleaf LLC (WonderLeaf), a marijuana-infused products production facility in Aurora, Colorado. The Company manufactures a range of premium pre-rolled joints. The Company has offered cannabis products focusing on two primary categories: Branded Products and Processing Business. It plans to pursue production of brands of pre-rolled joints and other processed marijuana products under newly created brand names. It also plans to explore licensing existing brands from other states and producing them in Colorado.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BESPOKE EXTRACTS, INC.	+322.54%	813K
ELI LILLY AND COMPANY	+32.36%	698B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.40%	358B
MERCK & CO., INC.	+19.46%	328B
ABBVIE INC.	+3.50%	283B
ASTRAZENECA PLC	+16.34%	238B
NOVARTIS AG	+6.68%	203B
ROCHE HOLDING AG	-9.08%	198B
AMGEN INC.	+8.62%	165B

Other Pharmaceuticals